Profenamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Anypodetos (talk | contribs) at 18:45, 28 August 2012 (Marked INN/BAN; removed redundant refs template). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Profenamine
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Pharmacokinetic data
Protein binding93%
Elimination half-life1 to 2 hours
Identifiers
  • N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.007.566 Edit this at Wikidata
Chemical and physical data
FormulaC19H24N2S
Molar mass312.473 g/mol g·mol−1
3D model (JSmol)
  • S2c1ccccc1N(c3c2cccc3)CC(N(CC)CC)C
  • InChI=1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3 checkY
  • Key:CDOZDBSBBXSXLB-UHFFFAOYSA-N checkY
  (verify)

Profenamine (INN, trade names Parsidol, Parsidan, Parkin), also known as ethopropazine (BAN), is a phenothiazine derivative used as an antiparkinsonian agent that has anticholinergic, antihistamine, and antiadrenergic actions. It is also used in the alleviation of the extrapyramidal syndrome induced by drugs such as other phenothiazine compounds, but, like other compounds with antimuscarinic properties, is of no value against tardive dyskinesia.

Chemistry

Ethopropazine, 10-(2-diethylaminopropyl) phenothiazine, is synthesized by alkylation of phenothiazine using 1-diethylamino-2-propylchloride in the presence of sodium amide.

References